tiprankstipranks
Advertisement
Advertisement

CLLS Stock Latest News

Cellectis Unveils Strong Early CAR-T Data for Lasme-cel and Eti-cel at EHA 2026
Company AnnouncementsCellectis Unveils Strong Early CAR-T Data for Lasme-cel and Eti-cel at EHA 2026
2d ago
6K
CLLS
Cellectis Gains FDA RMAT Status for Allogeneic CAR-T lasme-cel in r/r B-ALL
PremiumCompany Announcements
Cellectis Gains FDA RMAT Status for Allogeneic CAR-T lasme-cel in r/r B-ALL
3d ago
6K
CLLS
Cellectis granted RMAT designation for lasmecabtagene timgedleucel from FDA
PremiumThe Fly
Cellectis granted RMAT designation for lasmecabtagene timgedleucel from FDA
3d ago
CLLS
Cellectis initiated with an Overweight at Barclays
PremiumThe Fly
Cellectis initiated with an Overweight at Barclays
16d ago
CLLS
Cellectis Calls June 25, 2026 Shareholders’ Meeting to Approve 2025 Results and Broad Capital-Issuance Powers
PremiumCompany Announcements
Cellectis Calls June 25, 2026 Shareholders’ Meeting to Approve 2025 Results and Broad Capital-Issuance Powers
23d ago
6K
CLLS
Cellectis Sets June 25, 2026 Date for Annual Shareholders Meeting in Paris
PremiumCompany AnnouncementsCellectis Sets June 25, 2026 Date for Annual Shareholders Meeting in Paris
23d ago
6K
CLLS
Cellectis to present clinical data on lasme-cel, eti-cel at EHA Congress
Premium
The Fly
Cellectis to present clinical data on lasme-cel, eti-cel at EHA Congress
1M ago
CLLS
Cellectis to Unveil Key Lasme-cel and Eti-cel Data at EHA 2026
Premium
Company Announcements
Cellectis to Unveil Key Lasme-cel and Eti-cel Data at EHA 2026
1M ago
6K
CLLS
Cellectis reports Q1 adjusted EPS (16c) vs. (17c) last year
PremiumThe Fly
Cellectis reports Q1 adjusted EPS (16c) vs. (17c) last year
1M ago
CLLS
Cellectis sees cash runway into 4Q27
PremiumThe Fly
Cellectis sees cash runway into 4Q27
1M ago
CLLS
Cellectis Files Q1 2026 Interim Financials with U.S. SEC
PremiumCompany Announcements
Cellectis Files Q1 2026 Interim Financials with U.S. SEC
1M ago
6K
CLLS
Cellectis Q1 2026 Results Highlight CAR-T Pipeline Milestones, New Epigenetic Platform and Licensing Dispute
PremiumCompany Announcements
Cellectis Q1 2026 Results Highlight CAR-T Pipeline Milestones, New Epigenetic Platform and Licensing Dispute
1M ago
6K
CLLS
CLLS Earnings this Week: How Will it Perform?
PremiumPre-EarningsCLLS Earnings this Week: How Will it Perform?
1M ago
CLLS
Cellectis to Release First-Quarter 2026 Results on May 11
Premium
Company Announcements
Cellectis to Release First-Quarter 2026 Results on May 11
1M ago
6K
CLLS
Cellectis Showcases Safer Epigenetic Gene-Silencing Platform Ahead of ASGCT 2026
Premium
Company Announcements
Cellectis Showcases Safer Epigenetic Gene-Silencing Platform Ahead of ASGCT 2026
2M ago
6K
CLLS
Cellectis Highlights Positive Pivotal Interim Data for Allogeneic CAR-T Partnered Cema-cel
PremiumCompany Announcements
Cellectis Highlights Positive Pivotal Interim Data for Allogeneic CAR-T Partnered Cema-cel
2M ago
6K
CLLS
Cellectis highlights Allogene ALPHA3 trial data, potential milestone payments
PremiumThe Fly
Cellectis highlights Allogene ALPHA3 trial data, potential milestone payments
2M ago
ALLO
CLLS
Cellectis Posts 2025 Results, Highlights Strong Allogeneic CAR-T Data and Cash Runway Into 2027
PremiumCompany Announcements
Cellectis Posts 2025 Results, Highlights Strong Allogeneic CAR-T Data and Cash Runway Into 2027
3M ago
6K
CLLS
Cellectis S.A. Sets March 19 Release Date for Q4 and Full-Year 2025 Results
PremiumCompany Announcements
Cellectis S.A. Sets March 19 Release Date for Q4 and Full-Year 2025 Results
3M ago
6K
CLLS
CLLS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsCLLS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
CLLS
Cellectis Sets 2026 Clinical Milestones and Extends Cash Runway Into H2 2027
Premium
Company Announcements
Cellectis Sets 2026 Clinical Milestones and Extends Cash Runway Into H2 2027
5M ago
6K
CLLS
Cellectis initiated with a Buy at Clear Street
Premium
The Fly
Cellectis initiated with a Buy at Clear Street
6M ago
CLLS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >